The Krause lab focuses on hematopoiesis, leukemia, and cell therapies including bone marrow transplantation and PSC-based treatment for hypoparathyroidism.
Yale Univ
Joined July 2009
- Tweets1.4K
- Following932
- Followers1.4K
- Likes1.3K
Diane Krause retweeted
Research led by @m_y_mayday uncovered how a mutant protein drives rare childhood leukemia #AMKL by hijacking RNA + Wnt signaling. Targeting these pathways with experimental inhibitors suppressed #leukemia growth. yalecancercenter.org/news-ar…
@BloodPortfolio @Krauselab_Yale
So proud of this team effort!
Yale Study: Potential Treatment Pathway Found for Rare and Aggressive Leukemia @m_y_mayday @BianconGiulia @tomalistar @Krauselab_Yale @Halene_lab @YaleCancer @YaleMed @BloodPortfolio #leusm #hematology
onclive.com/view/yale-study-…
Diane Krause retweeted
ASH Bridge Award direct cost floor was already raised to $500K/yr. Now the number of applications funded is dramatically increasing, with a rapid turn around...and a brand new additional cycle this year. @ASH_hematology
Well said - this needs to go vira. standupforscience.net/bethes…
🚨 @elonmusk, we need your attention! 🚨
A proposed 40% cut to the NIH budget will have catastrophic consequences for patients, biotech, academics, and most importantly, our economy.
Here's why -->
🚨 @elonmusk, we need your attention! 🚨
A proposed 40% cut to the NIH budget will have catastrophic consequences for patients, biotech, academics, and most importantly, our economy.
Here's why -->
.@rosadelauro @ChrisMurphyCT @SenBlumenthal Please continue to make medical research a priority by finalizing the FY2025 Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) spending bill with a robust investment in the NIH as soon as possible.
Why would the NIH cancel study sections in response to an Exec order to discontinue communication with the public? these are private and confidential meetings. the public is not there.
This is why my laboratory is working on developing a cell therapy for hypoparathyroidism.@HypoPARAassoc
Andrea Ligler - post surgical hypoPARA patient youtu.be/rJTHU7DesEE?si=2KzI… via @YouTube
excited to announce that the Yale Dept. of Cell Biology postdoc recruitment initiative, SUPR, is now official and posted on the department website:
medicine.yale.edu/cellbio/po…
Why have major newspapers refused to endorse a presidential candidate?
"Anticipatory Obedience" - similar to when the Nazi party was coming into power. - really.
theguardian.com/us-news/2024…
Proud of all authors of our paper showing RUNX1 is activated by CDK9 to promote megakaryocyte fate in primary human progenitors. Let us know what you think!
@NKwonHem @EvrettT @mancuso_rubia @Yalelabmed @Yale_LabMed @RUNX1Research
authors.elsevier.com/a/1j%7E…
So proud of Garg_lab in @Yale_LabMed
Deeply honored for our laboratory to receive a NIH Director's New Innovator Award from @NIH_CommonFund. Delighted to see what we can learn about the origins of heterogeneity in cell systems over the coming years! #NIHHighRisk
From this article,scientificamerican.com/artic…
"Project 2025, the sweeping right-wing blueprint for a new kind of U.S. presidency, would sabotage science-based policies that address climate change, the environment, abortion, health care access, technology and education."
Diane Krause retweeted
MARK YOUR CALENDARS! 📅✅Yale #LabMed & #Pathology invite you to our #PathologyOpenHouse. Join one of our virtual open houses featuring our Residency Program Leadership and residents @YalePathRes Tuesday, August 27th 6 PM - 7 PM or Sunday, September 8th 2 PM - 3 PM
Registration QRC attached. PLEASE RETWEET @Yale_labmed & @Yalepathology – at New Haven, CT
ALT poster with qrc code that is advertising 2 virtual open houses for yale pathology residency program.
Very proud that our discovery that phophoserine RUNX1 promoted megakaryocyte (MK) fate specification in primary human MEP is out!
@YaleCCEH @Yale_LabMed Work of many including the amazing @NKwonHem
sciencedirect.com/science/ar…